HPV Prevention Resources

What to Know About HPV and Cancer

HPV is a group of more than 200 related viruses, some of which are spread through vaginal, anal and oral sex, and other intimate forms of skin-to-skin contact. Because HPV can sometimes lead to cancer later in life, it's important to know the low- and high-risk forms, when to get vaccinated and where to get the right care for HPV-related cancers.

Cancers Caused by HPV

HPV types fall into two groups: low risk and high risk. Low-risk HPV infections typically don't cause any disease. However, a few low-risk HPV types can cause warts on or around the genitals, anus, mouth or throat. These are the infections that your immune system usually controls, so they don’t cause cancer.

High-risk HPV infections that persist can cause cancer. Sometimes, HPV infections are not effectively controlled by your immune system. When a high-risk HPV infection persists for many years, it can lead to cell changes that, if untreated, may get worse over time and become cancer.

Getting the HPV Vaccine

The HPV vaccine series is recommended for girls and boys at the age of 11 or 12; the series can be started at age nine. For young people who didn’t get vaccinated on time, HPV vaccination is recommended up to age 26.

Can the HPV vaccine be given at older ages?

Yes, the vaccine can be given to adults between the ages of 27 and 45 who didn’t receive all vaccine doses earlier. Adults in this age group benefit less from the vaccine because they are more likely to have been exposed to HPV already. But if you are concerned that you are at risk for new HPV infections, you should talk with your health care provider about whether the vaccine may be right for you.

AdventHealth Published HPV Experts

8 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
Adnan Akhtar, MD

Adnan Akhtar, MD

Hematology and Oncology

Mark Harvey, MD

Radiation Oncology

Photo of Henry N. Ho, MD, FACS

Henry N. Ho, MD, FACS

Co-Medical Director (Head & Neck), Otolaryngology Specialist, Surgeon
Fatma Levent, MD

Fatma Levent, MD

Pediatric Infectious Diseases

Person placeholder image

Scott Magnuson, MD

Tarek Mekhail, MD

Hematology and Oncology

Lingbin Meng, MD

Lingbin Meng, MD

Internal Medicine

Nathalie McKenzie, MD

Nathalie McKenzie, MD

Gynecologic Oncology, OBGYN

Our Programs for HPV-Related Cancers

Sometimes, an HPV infection can lead to gynecologic, gastrointestinal and head and neck cancers. And if it does for you or someone you love, you can rest assured that we'll be there. Through constant research and dedicated programs, we provide the utmost care for cancers caused by HPV.

AdventHealth HPV Clinical Publications

A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311

Prognostic Significance of Extranodal Extension in HPV-Mediated Oropharyngeal Carcinoma: A Systematic Review and Meta-analysis

Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma

Role of human papillomavirus in laryngeal squamous cell carcinoma: A meta-analysis of cohort study

Long-term Analysis of Transorally Resected p16 + Oropharynx Cancer: Outcomes and Prognostic Factors

Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis

Erratum to: Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy

Comparison of Unilateral Versus Bilateral Intensity-Modulated Radiotherapy for Surgically Treated Squamous Cell Carcinoma of the Palatine Tonsil

Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy

Oncologic Outcomes of Selective Neck Dissection in HPV-Related Oropharyngeal Squamous Cell Carcinoma

De-escalation of radiotherapy for the treatment of HPV-associated head and neck cancer: A case report and a word of caution

Pathology-based Staging for HPV-positive Squamous Carcinoma of the Oropharynx

Does elimination of planned postoperative radiation to the primary bed in p16-positive, transorally-resected oropharyngeal carcinoma associate with poorer outcomes?

What Is New in Human Papillomavirus– Related Lower Anogenital Tract Disease Prevention and Screening?

Screening for Anal Cancer in Women

Transoral Robotic versus Open Surgical Approaches to Oropharyngeal Squamous Cell Carcinoma by Human Papillomavirus Status

Most Recent Stories

4 items. To interact with these items, press Control-Option-Shift-Right Arrow.

HPV Community Resources

HPV Information for Parents and Providers
Center for Disease Control and Prevention (CDC)

HPV Vaccination Safety and Effectiveness
Center for Disease Control and Prevention (CDC)

Florida HPV Elimination Goals
Florida Cancer Control and Research Advisory Council (CCRAB)

Cervical Cancer Screening Recommendations
Cervical Cancer - American College of Obstetrics and Gynecology (ACOG)

HPV Advocacy and Resources
HVP Alliance